Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • exome CNV: remove duplicate reads?

    Hi all,

    I just want to know if you remove the duplicate reads when detecting CNVs using whole exome sequencing data. It seems that for SNV calling duplicate removal is widely accepted. How about CNV detection?

    Thank you.

  • #2
    Hi,

    Yes, PCR amplification distorts the signal of expected correlation between underlying copy number and read depth. Therefore, it makes sense to try and remove the reads that are clearly duplicates and artifacts of the PCR. Of course, there may be more subtle sample-specific and target-specific artifacts (or reads not marked as duplicates, depending on the stringency of the marking), so it's still necessary to "clean up" the data to detect copy number.

    We describe in our recent paper our approach to doing this, which includes both data-driven normalization using PCA (principal component analysis) and using an HMM (hidden Markov model) to statistically genotype CNV:
    Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. American Journal of Human Genetics, 91:597-607, Oct 2012.



    And, XHMM, our downloadable software for detecting CNV from exome data can be found here:


    Best,
    Menachem

    Comment


    • #3
      Thank you very much Menachem. It is great to have published papers to support the duplicate removal. And thanks for the software. I will try it.

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Understanding Genetic Influence on Infectious Disease
        by seqadmin




        During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

        Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
        09-09-2024, 10:59 AM
      • seqadmin
        Addressing Off-Target Effects in CRISPR Technologies
        by seqadmin






        The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
        08-27-2024, 04:44 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, Yesterday, 02:44 PM
      0 responses
      8 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-06-2024, 08:02 AM
      0 responses
      145 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-03-2024, 08:30 AM
      0 responses
      152 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 08-27-2024, 04:40 AM
      0 responses
      159 views
      0 likes
      Last Post seqadmin  
      Working...
      X